Nautilus Biotechnology, Inc. Letters of Credit Outstanding, Amount
Nautilus Biotechnology, Inc. (NAUT) had Letters of Credit Outstanding, Amount of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Other Liabilities and Financial Instruments Subject to Mandatory Redemption
us-gaap:LettersOfCreditOutstandingAmount · last filed 2026-07-28
- 2026-06-30: Letters of Credit Outstanding, Amount $1.00M.
- 2026-03-31: Letters of Credit Outstanding, Amount $1.00M.
- 2025-12-31: Letters of Credit Outstanding, Amount $1.00M.
- 2025-09-30: Letters of Credit Outstanding, Amount $1.00M.
| Period end | Letters of Credit Outstanding, Amount | Letters of Credit Outstanding, Amount as first filed |
|---|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $1.00M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $1.00M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.00M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $1.00M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $1.00M 10-Q · filed 2025-04-29 | |
| 2024-09-30 | $1.00M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $1.00M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $1.00M 10-Q · filed 2024-04-30 | |
| 2023-06-30 | $600.00K 10-Q · filed 2023-08-02 | |
| 2022-11-30 | $100.00K 10-K · filed 2024-02-28 | |
| 2021-12-31 | $200.00K 10-K · filed 2024-02-28 | $800.00K 10-K · filed 2022-02-24 |
| 2020-12-31 | $600.00K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |